跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 899 条关于
“NEOSUMMIT-03”
全部
899
临床试验
219
药物
434
机构
109
资讯
137
去年
Phase 2 Trial Shows Promise: Tislelizumab Plus Chemotherapy Demonstrates Strong Results in Advanced Gastroesophageal Cancer
2个月前
Chinese Researchers Discover Novel HLA Allele HLA-DQB1*03:03:38 with Clinical Promise
去年
NS Pharma's NS-050/NCNP-03 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy
去年
Metabolics Pharma's ENT-03 Shows Promise in Phase 1a Trial for Obesity and Type 2 Diabetes
去年
Aileron Therapeutics Presents Positive Phase 1b Data for LTI-03 in Idiopathic Pulmonary Fibrosis
5年前
Shingrix Label Updated with Guillain-Barré Syndrome Warning Following FDA Review
9个月前
Ventus Therapeutics Doses First Patient in Phase 2 Trial of VENT-03 cGAS Inhibitor for Lupus
去年
Aileron Therapeutics' LTI-03 Shows Promise in Idiopathic Pulmonary Fibrosis Trial
7个月前
Trace Biosciences Receives FDA IND Clearance for First-in-Class Nerve-Specific Imaging Agent LGW16-03
8个月前
Osel Launches First-Ever Pivotal Trial of Microbiome-Based Cancer Therapy MO-03 for Advanced Renal Cell Carcinoma
第 1 页,共 14 页
上一页
下一页